Longeveron (LGVN) Stock: Buy, Sell, or Hold?
LGVN - Longeveron Inc. Common Stock
$1.60
0.01 (0.63%)
▲
5d:
+15.11%
30d:
-45.02%
90d:
+161.95%
HOLD
MODERATE Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 03, 2026
10d
Get Alerted When LGVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: LGVN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: LGVN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: LGVN is currently trading at $1.60, which is considered slightly low relative to its 30-day fair value range of $1.26 to $4.16.
Technical Outlook: Technically, LGVN is in a uptrend. Immediate support is located at $1.31, while resistance sits at $2.55.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $61.25 (+3728.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, LGVN is in a uptrend. Immediate support is located at $1.31, while resistance sits at $2.55.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $61.25 (+3728.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.26 -
$4.16
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 3728.1% below Wall St target ($61.25)
- NEUTRAL: Bottoming setup forming (58/100) — watch for confirmation
Trading Range Analysis
30-Day Trading Range
$1.26 -
$4.16
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.31
Resistance Level
$2.55
Current Trend
Uptrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.32
Wall Street Target
$61.25
(+3728.1%)
Revenue Growth (YoY)
-9.2%
Share & Embed Analysis
Last updated: October 23, 2026 6:46 PM ET
Data refreshes hourly during market hours. Next update: 7:46 PM
Data refreshes hourly during market hours. Next update: 7:46 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LGVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 53 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 64 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 48 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$63 | 66 BUY |
|
IMNM
Immunome Inc |
STRONG BUY
16 analysts |
$35 | 59 HOLD |
